At the recent 2025 congress of the European Society for Medical Oncology (ESMO), researchers led by Fedro A. Peccatori, MD, presented compelling new results from the POSITIVE trial — a study designed for pre-menopausal women with early hormone-receptor positive breast cancer who wish to pursue pregnancy after treatment. The findings mark a significant advance for young women …
